Thermo Fisher Scientific Provides Process Overview for the Announcement of Final Offer Results WALTHAM, Mass., Aug. 11, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today provided an overview of the process to report the final results from the acceptance period of its offer to acquire all of the... Read more
New Thermo Scientific Selectris Filters Push Cryo-EM Boundaries with Atomic Resolution Zero-loss energy filters enable life scientists to view protein structures in unprecedented detail HILLSBORO, Ore., Aug. 10, 2020 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, today introduced two breakthrough imaging filters, the Thermo Scientific Selectris Imaging Filter and the Thermo Scientific... Read more
Waukesha, WI – August 10, 2020 – At this year’s virtual ISMRM meeting, GE Healthcare is showcasing new technologies to enable neuro research to better understand Alzheimer’s disease and traumatic brain injury, as well as accelerate clinical translation. The 510(k)-pending SIGNA 7.0T [1], as well as research devices SIGNA ultra-high performance (UHP) 3.0T and the... Read more
Thermo Fisher Scientific Develops COVID-19 Antibody Assay Targeting Transplant Community WEST HILLS, Calif., Aug. 10, 2020 /PRNewswire/ — Thermo Fisher Scientific continues to expand its response to the COVID-19 pandemic, developing a new serological assay targeted towards transplant candidates and recipients that can detect antibodies directed against COVID-19 (SARS-CoV-2). The assay will be provided under the company’s... Read more
FRANKFURT, Germany–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced its support of a worldwide collaborative project that investigates the structures, dynamics, function and binding of SARS-CoV-2 viral RNA and proteins using high-field nuclear magnetic resonance (NMR) spectroscopy. The Covid19-NMR (https://covid19-nmr.de/) consortium was initiated at Goethe University (GU) in Frankfurt, Germany, and leverages the extensive experience... Read more
Basel, 10 August 2020 In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA Evrysdi helped infants survive without permanent ventilation and achieve the ability to sit without support, a key motor milestone not... Read more
Etrolizumab met its primary endpoint of inducing remission versus placebo for people with ulcerative colitis in only two of three studies Etrolizumab failed to meet its primary endpoint versus placebo as maintenance therapy in people with ulcerative colitis Analyses of these data are ongoing to better understand the results Pivotal phase III study of etrolizumab... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast. UBS Genomics 2.0 and MedTech Innovations Virtual SummitWednesday, August 12, 2020 at 10:00am Pacific Time The live webcasts can be accessed in the Investor Info section of Illumina’s web site... Read more
Christian O. Henry Named Chief Executive OfficerJohn F. Milligan, Ph.D. Named Chairman of the BoardBen Gong Named Interim CFOMENLO PARK, Calif., Aug. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Christian O. Henry as President... Read more
Crosslinking Mass Spectrometry (XL-MS) Now Can Leverage the PhoX Crosslinker and TIMS/PASEF Methods with the Large-Scale Use of Accurate Collision Cross Sections (CCS) BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced a collaboration with Utrecht University to advance the study of the 3-D structures and interactions of proteins by mass spectrometry. The laboratory of... Read more